This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB08557/identifier/chemspider/
n13http://bio2rdf.org/drugbank:
n8http://linked.opendata.cz/resource/drugbank/drug/DB08557/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n14http://linked.opendata.cz/resource/drugbank/drug/DB08557/identifier/pubchem-compound/
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n4http://linked.opendata.cz/resource/drugbank/drug/DB08557/identifier/pubchem-substance/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/ontology/drugbank/
n5http://linked.opendata.cz/resource/drugbank/drug/DB08557/identifier/drugbank/
n7http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08557
rdf:type
n6:Drug
n6:group
experimental
owl:sameAs
n11:DB08557 n13:DB08557
dcterms:title
2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide
adms:identifier
n4:99445028 n5:DB08557 n8:SNX n9:22378241 n14:24812721
n6:IUPAC-Name
n7:271B63B9-363D-11E5-9242-09173F13E4C5
n6:InChI
n7:271B63BF-363D-11E5-9242-09173F13E4C5
n6:Molecular-Formula
n7:271B63BE-363D-11E5-9242-09173F13E4C5
n6:Molecular-Weight
n7:271B63BB-363D-11E5-9242-09173F13E4C5
n6:Monoisotopic-Weight
n7:271B63BC-363D-11E5-9242-09173F13E4C5
n6:SMILES
n7:271B63BD-363D-11E5-9242-09173F13E4C5
n6:Water-Solubility
n7:271B63B7-363D-11E5-9242-09173F13E4C5
n6:logP
n7:271B63B8-363D-11E5-9242-09173F13E4C5 n7:271B63B5-363D-11E5-9242-09173F13E4C5
n6:logS
n7:271B63B6-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Acceptor-Count
n7:271B63C5-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Donor-Count
n7:271B63C6-363D-11E5-9242-09173F13E4C5
n6:InChIKey
n7:271B63C0-363D-11E5-9242-09173F13E4C5
n6:Polar-Surface-Area--PSA-
n7:271B63C1-363D-11E5-9242-09173F13E4C5
n6:Polarizability
n7:271B63C3-363D-11E5-9242-09173F13E4C5
n6:Refractivity
n7:271B63C2-363D-11E5-9242-09173F13E4C5
n6:Rotatable-Bond-Count
n7:271B63C4-363D-11E5-9242-09173F13E4C5
n6:Bioavailability
n7:271B63CB-363D-11E5-9242-09173F13E4C5
n6:Ghose-Filter
n7:271B63CD-363D-11E5-9242-09173F13E4C5
n6:MDDR-Like-Rule
n7:271B63CE-363D-11E5-9242-09173F13E4C5
n6:Number-of-Rings
n7:271B63CA-363D-11E5-9242-09173F13E4C5
n6:Physiological-Charge
n7:271B63C9-363D-11E5-9242-09173F13E4C5
n6:Rule-of-Five
n7:271B63CC-363D-11E5-9242-09173F13E4C5
n6:Traditional-IUPAC-Name
n7:271B63BA-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-acidic-
n7:271B63C7-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-basic-
n7:271B63C8-363D-11E5-9242-09173F13E4C5